{
    "url_original": "https://www.wsj.com/articles/fda-raises-concerns-about-china-developed-drugs-11644408180?mod=business_lead_pos2",
    "url": "fda-raises-concerns-about-china-developed-drugs-11644408180",
    "title": "FDA Raises Concerns About China-Developed Drugs",
    "sub_head": "Agency could slow the plans of big Western drugmakers to sell Chinese-tested medicines in U.S.",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-482302?width=860&height=573",
    "image_1": "im-482302.jpg",
    "time": "2022-02-09 07:03:00",
    "body": "U.S. regulators are poised to tap the brakes on approving dozens of cancer drugs and other new medicines developed in China.<br />The regulators have expressed concerns about the quality of studies largely conducted in China and whether the results can apply to patients in the U.S."
}